Columbia Care Inc. acquired the Healing Center San Diego for approximately $15 million. (2024)

FAQs

Who bought Columbia Care? ›

Chicago-based Cresco Labs' acquisition of Columbia Care, valued at approximately $2 billion last March, is contingent on both companies selling off a number of assets.

Market cap: $0.52 Billion

As of April 2024 Columbia Care has a market cap of $0.52 Billion. This makes Columbia Care the world's 5923th most valuable company by market cap according to our data.

The Cannabist Company, formerly known as Columbia Care, is one of the largest and most experienced cultivators, manufacturers and providers of cannabis products and related services, with licenses in 15 U.S. jurisdictions.

Last July, Cresco Labs and Columbia Care announced that the cannabis companies were terminating their blockbuster, $2 billion dollar merger agreement, a complex deal between two of the largest multistate operators in the country that was 16 months in the making.

Nicholas Vita is the Co-Founder and Chief Executive Officer at Columbia Care.

Michael Abbott co-founded Columbia Care with Chief Executive Officer Nicholas Vita in 2012 and helped build the Company into one of the largest multi-state medical and adult-use cannabis providers in the U.S. In his continuing role as Chairman, Abbott will remain integrally involved in company oversight and governance.

What do analysts say about Columbia Care? Columbia Care's analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.

University endowments are big (Columbia has $14 billion) but are a drop in the ocean of capital swilling around big companies. Microsoft, one of the stocks protesters want sold, alone is valued at $3 trillion. The impact of even a lot of universities selling would be negligible.

The company offers products spanning flower, edibles, oils and tablets, and manufactures popular brands including Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber. For more information, please visit www.cannabistcompany.com.

Total debt on the balance sheet as of June 2023 : $0.55 B

According to Columbia Care's latest financial reports the company's total debt is $0.55 B. A company's total debt is the sum of all current and non-current debts.

Why is Columbia Care stock dropping? ›

Columbia Care is down over 90% from its IPO with unprofitability and an increasingly precarious cash position forming a headwind. The company's cash and equivalents stood at $50 million as of the end of its fiscal 2022 fourth quarter.

Columbia Care (OTCQX:CCHWF) said Tuesday it will voluntarily delist its common shares from the Canadian Securities Exchange. The delisting will be effective as of market close on August 2, 2023. The company will continue trading on Cboe Canada, previously known as NEO Exchange.

Pressured by a tough macroeconomic environment and the slow pace of federal cannabis reform, MSOs began exiting challenging state markets over the past year and aiming to “optimize” operations in more lucrative markets. Cresco Labs exited Arizona and Maryland in recent months, a company spokesperson confirmed.

What do analysts say about Columbia Care? Columbia Care's analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.